Literature DB >> 26185881

Esophagus adenocarcinoma in a young patient with celiac disease; Is celiac disease a predisposing factor for esophagus adenocarcinoma as well as squamous cell carcinoma?

Baghbanian Mahmud1, Amirbeigy Mohammadkazem, Salmanroghani Hasan, Binesh Fariba, Baghbanian Ali, Zare-Khormizi Mohamadreza.   

Abstract

We report a 36-year-old female with longstanding oily diarrhea and new-onset dysphagia that was diagnosed as celiac disease and esophagus adenocarcinoma. Celiac is a multisystemic autoimmune disease associated with a longstanding inflammatory process, especially in the gastrointestinal tract. This chronic inflammation may lead to a modest increase in neoplasia risk. There is a modest increased risk of malignancy in celiac disease, particularly adenocarcinoma and T-cell lymphoma of the small intestine and squamous cell carcinoma (SCC) of the esophagus, mouth, and pharynx. Although there is an association between SCC of the esophagus and celiac disease, there are no reports in the English literature about a relationship between celiac disease and esophageal adenocarcinoma. This case shows that as well as SCC, adenocarcinoma of the esophagus may also occur in patients with longstanding celiac disease.

Entities:  

Mesh:

Year:  2014        PMID: 26185881     DOI: 10.1007/s12328-014-0509-z

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  11 in total

1.  Mortality in patients with coeliac disease and their relatives: a cohort study.

Authors:  G Corrao; G R Corazza; V Bagnardi; G Brusco; C Ciacci; M Cottone; C Sategna Guidetti; P Usai; P Cesari; M A Pelli; S Loperfido; U Volta; A Calabró; M Certo
Journal:  Lancet       Date:  2001-08-04       Impact factor: 79.321

2.  Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease.

Authors:  Peter Elfström; Fredrik Granath; Weimin Ye; Jonas F Ludvigsson
Journal:  Clin Gastroenterol Hepatol       Date:  2011-06-30       Impact factor: 11.382

3.  Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis.

Authors:  Johan Askling; Martha Linet; Gloria Gridley; Trond S Halstensen; Karin Ekström; Anders Ekbom
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  Malignancy in coeliac disease--effect of a gluten free diet.

Authors:  G K Holmes; P Prior; M R Lane; D Pope; R N Allan
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

5.  Malignancy in a 19-year experience of adult celiac disease.

Authors:  W S Selby; N D Gallagher
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

6.  Coeliac disease and malignancy.

Authors:  C M Swinson; G Slavin; E C Coles; C C Booth
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

7.  Cancers of the esophagus and carbonated beverage consumption: a population-based case-control study.

Authors:  Torukiri I Ibiebele; Maria Celia Hughes; Peter O'Rourke; Penelope M Webb; David C Whiteman
Journal:  Cancer Causes Control       Date:  2008-01-30       Impact factor: 2.506

8.  Malignancy in adult celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

9.  Mortality in celiac disease.

Authors:  R F Logan; E A Rifkind; I D Turner; A Ferguson
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

10.  Abdominal obesity and the risk of esophageal and gastric cardia carcinomas.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

View more
  1 in total

1.  Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: Consequences for follow-up: Celiac disease, lymphoma and GI carcinoma.

Authors:  Tom van Gils; Petula Nijeboer; Lucy Ih Overbeek; Michael Hauptmann; Daan Ar Castelijn; Gerd Bouma; Chris Jj Mulder; Flora E van Leeuwen; Daphne de Jong
Journal:  United European Gastroenterol J       Date:  2018-09-12       Impact factor: 4.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.